Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00680095 · ClinicalTrials.gov registry record · Phase 1
Cumulative Irritation Test
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 37
- Enrollment target
NCT00680095 is a Phase 1 study that has completed, run by Pfizer. The registered enrollment target is 37 participants.
The verdict
NCT00680095, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 37 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the cumulative irritation potential of the products listed by the Sponsor.
Interventions
- DRUG AN2690
- OTHER AN2690 Solution, Vehicle
- OTHER Sodium Lauryl Sulfate, 0.5%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2007-01-22 |
| Est. Completion | 2007-02-19 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00680095
The ClinicalTrials.gov registry entry for NCT00680095 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which AN2690 is the first listed.
NCT00680095 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00680095 about?
NCT00680095 is a clinical study titled "Cumulative Irritation Test". The purpose of this study is to determine the cumulative irritation potential of the products listed by the Sponsor.
What is the current status of trial NCT00680095?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 37 participants. The study started on 2007-01-22. Estimated completion is 2007-02-19.
What interventions are being tested in trial NCT00680095?
The interventions under investigation include: AN2690 (DRUG), AN2690 Solution, Vehicle (OTHER), Sodium Lauryl Sulfate, 0.5% (OTHER).
Who is sponsoring clinical trial NCT00680095?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.